Bomgaars LR - Search Results

1

Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device.

Steiner ME, Bomgaars LR, Massicotte MP; Berlin Heart EXCOR Pediatric VAD IDE study investigators. Steiner ME, et al. Among authors: bomgaars lr. ASAIO J. 2016 Nov/Dec;62(6):719-727. doi: 10.1097/MAT.0000000000000434. ASAIO J. 2016. PMID: 27556152 Free PMC article.

2

Prospective trial of a pediatric ventricular assist device.

Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS; Berlin Heart Study Investigators. Fraser CD Jr, et al. N Engl J Med. 2012 Aug 9;367(6):532-41. doi: 10.1056/NEJMoa1014164. N Engl J Med. 2012. PMID: 22873533 Free article. Clinical Trial.

3

Anticoagulation therapy trends in children supported by ventricular assist devices: a multi-institutional study.

Moffett BS, Cabrera AG, Teruya J, Bomgaars L. Moffett BS, et al. ASAIO J. 2014 Mar-Apr;60(2):211-5. doi: 10.1097/MAT.0000000000000037. ASAIO J. 2014. PMID: 24399058

4

Pharmacogenetics and pediatric cancer.

Bomgaars L, McLeod HL. Bomgaars L, et al. Cancer J. 2005 Jul-Aug;11(4):314-23. doi: 10.1097/00130404-200507000-00007. Cancer J. 2005. PMID: 16197721 Review.

5

Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.

Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SM. Bernardi RJ, et al. Cancer Chemother Pharmacol. 2008 Jul;62(2):355-61. doi: 10.1007/s00280-007-0601-x. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17909804 Clinical Trial.

6

Low prevalence and assay discordance of "aspirin resistance" in children.

Yee DL, Dinu BR, Sun CW, Edwards RM, Justino H, Teruya J, Bray PF, Bomgaars L. Yee DL, et al. Pediatr Blood Cancer. 2008 Jul;51(1):86-92. doi: 10.1002/pbc.21465. Pediatr Blood Cancer. 2008. PMID: 18253960

7

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.

Raman VS, Mason KJ, Rodriguez LM, Hassan K, Yu X, Bomgaars L, Heptulla RA. Raman VS, et al. Diabetes Care. 2010 Jun;33(6):1294-6. doi: 10.2337/dc09-1959. Epub 2010 Mar 23. Diabetes Care. 2010. PMID: 20332358 Free PMC article. Clinical Trial.

8

Comparison of anti-Xa levels in obese and non-obese pediatric patients receiving treatment doses of enoxaparin.

Richard AA, Kim S, Moffett BS, Bomgaars L, Mahoney D Jr, Yee DL. Richard AA, et al. J Pediatr. 2013 Feb;162(2):293-6. doi: 10.1016/j.jpeds.2012.07.047. Epub 2012 Sep 5. J Pediatr. 2013. PMID: 22959138

9

Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge.

Moffett BS, Kim S, Bomgaars LR. Moffett BS, et al. Among authors: bomgaars lr. Pediatr Blood Cancer. 2013 Sep;60(9):1503-6. doi: 10.1002/pbc.24546. Epub 2013 Apr 20. Pediatr Blood Cancer. 2013. PMID: 23606286 Clinical Trial.

10

Response to warfarin therapy in obese pediatric patients dosed according to institutional guidelines.

Moffett BS, Bomgaars LR. Moffett BS, et al. Among authors: bomgaars lr. J Pediatr Hematol Oncol. 2014 Nov;36(8):e487-9. doi: 10.1097/MPH.0000000000000087. J Pediatr Hematol Oncol. 2014. PMID: 24458250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page